Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 13.375 GBX Market Closed
Market Cap: 55.2m GBX

Wall Street
Price Targets

CREO Price Targets Summary
Creo Medical Group PLC

Wall Street analysts forecast CREO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CREO is 56.1 GBX with a low forecast of 40.4 GBX and a high forecast of 73.5 GBX.

Lowest
Price Target
40.4 GBX
202% Upside
Average
Price Target
56.1 GBX
319% Upside
Highest
Price Target
73.5 GBX
450% Upside
Creo Medical Group PLC Competitors:
Price Targets
BIM
Biomerieux SA
7% Upside
EW
Edwards Lifesciences Corp
12% Upside
NNOX
Nano-X Imaging Ltd
102% Upside
HYPR
Hyperfine Inc
43% Upside
STIL
Stille AB
37% Upside
9996
Peijia Medical Ltd
3% Downside
SUS
Surgical Science Sweden AB
29% Upside
BFLY
Butterfly Network Inc
97% Upside

Revenue
Forecast

Revenue Estimate
Creo Medical Group PLC

The compound annual growth rate of Creo Medical Group PLC's revenue for the next 4 years is -10%.

N/A
Past Growth
-10%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Creo Medical Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

Net Income Estimate
Creo Medical Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CREO's stock price target?
Price Target
56.1 GBX

According to Wall Street analysts, the average 1-year price target for CREO is 56.1 GBX with a low forecast of 40.4 GBX and a high forecast of 73.5 GBX.

What is Creo Medical Group PLC's Revenue forecast?
Projected CAGR
-10%

The compound annual growth rate of Creo Medical Group PLC's revenue for the next 4 years is -10%.

Back to Top